Webinar Series: Trade Secrets are Not Intellectual Property – At Least Not in the European Union
Webinar | 02.11.20, 6:00 AM EST - 7:00 AM EST
Trade secrets are not intellectual property – at least not in the European Union (EU) under the EU Trade Secrets Directive. How are trade secrets defined in the EU vs the US? How do the US and EU judicial bodies differ in their view of trade secrets, and how does that protect, or leave vulnerable, your company’s most valuable information? How might cross-border (or transnational) companies protect their intellectual property assets and prepare for threats when subject to dual (EU/US) enforcement?
This webinar will guide you through the small differences in the language and theory behind the EU Trade Secrets Directive and the US Defend Trade Secrets Act (DTSA), and the important consequences these have on your trade secrets protection and strategy.
For more information, please visit these areas: Intellectual Property, Litigation and Trial, Intellectual Property Litigation, Trade Secrets, Brussels Practice
Contact
Participants
Insights
Webinar | 12.10.26
The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations
The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.
Webinar | 11.17.26
